N-[3-(4-chloro-7H-pyrrolo[2,3-d]pyrimidine-5-carbonyl)-2,4-difluorophenyl]-4-(fluoromethyl)benzenesulfonamide
C20H12ClF3N4O3S — CID 88937186
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[3-(4-chloro-7H-pyrrolo[2,3-d]pyrimidine-5-carbonyl)-2,4-difluorophenyl]-4-(fluoromethyl)benzenesulfonamide
N-[3-(4-chloro-7H-pyrrolo[2,3-d]pyrimidine-5-carbonyl)-2,4-difluorophenyl]-4-(fluoromethyl)benzenesulfonamide (PubChem CID 88937186) has the molecular formula C20H12ClF3N4O3S and a molecular weight of 480.86 g/mol. Its IUPAC name is N-[3-(4-chloro-7H-pyrrolo[2,3-d]pyrimidine-5-carbonyl)-2,4-difluorophenyl]-4-(fluoromethyl)benzenesulfonamide.
Molecular Properties
| Compound Name | N-[3-(4-chloro-7H-pyrrolo[2,3-d]pyrimidine-5-carbonyl)-2,4-difluorophenyl]-4-(fluoromethyl)benzenesulfonamide |
|---|---|
| PubChem CID | 88937186 |
| Molecular Formula | C20H12ClF3N4O3S |
| Molecular Weight | 480.86 g/mol |
| Exact Mass | 480.03 |
| IUPAC Name | N-[3-(4-chloro-7H-pyrrolo[2,3-d]pyrimidine-5-carbonyl)-2,4-difluorophenyl]-4-(fluoromethyl)benzenesulfonamide |
| SMILES | O=C(c1c(F)ccc(NS(=O)(=O)c2ccc(CF)cc2)c1F)c1c[nH]c2ncnc(Cl)c12 |
| InChI | InChI=1S/C20H12ClF3N4O3S/c21-19-15-12(8-25-20(15)27-9-26-19)18(29)16-13(23)5-6-14(17(16)24)28-32(30,31)11-3-1-10(7-22)2-4-11/h1-6,8-9,28H,7H2,(H,25,26,27) |
| InChIKey | VHLNZWZQGQUNJG-UHFFFAOYSA-N |
| XLogP | 4.39 |
| TPSA | 104.81 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 480.86 |
| LogP ≤ 5 | 4.39 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 88937186 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.